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http://dx.doi.org/10.1016/j.asjsur.20Summary Giant condyloma acuminatum (GCA), originally described by Buschke and Loe-
wenstein in 1925 as a lesion of the penis, is more rarely seen in the anorectum and is char-
acterized by clinical malignancy in the face of histologic benignity; however, malignant
transformation to frankly invasive squamous-cell carcinoma has been described in about
one-third of patients. In addition, malignant transformation has been reported in patients
with "ordinary" condylomata acuminata. Human papillomavirus, known to cause condylomata
acuminata, is also known to induce these tumors and was found in 96% of 63 cases reviewed
in the last 10 years. These lesions have a propensity for recurrence and a likelihood of malig-
nant transformation, and lead to significant mortality. Therefore, early and radical R0 exci-
sion, along with vigilant follow-up, provides the hope for cure. Conservative and/or
multimodal therapy has been reported in a few cases, but its effect is not yet proved. The
authors report one case of GCA; in addition, they reviewed the literature over the last 10
years and compared with previous reviews.
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44 F. Safi et al.1. Introduction
1.1. Verrucous carcinoma
Verrucous carcinoma (VC) of the skin and mucosa is an
uncommon, low-grade squamous-cell carcinoma (SCC),
characterized clinically as a slowly but relentlessly
enlarging warty tumor; histologically by local invasion with
minimal, if any, dysplasia; and biologically by a low inci-
dence of metastasis. Even if the tumor is large, has been
present for many years, and has penetrated into bone,
distant metastases are rare. It tends to appear in three
main sites: oropharynx, genitalia, and sole. However, it
may occur anywhere on the skin. Hence, there are four
clinicopathologic types. For this reason, it has been known
by several different names, usually related to anatomic
site: anourogenitaldgiant condyloma acuminatum (GCA),
BuschkeeLoewenstein tumor (BLT), giant malignant
condyloma, VC of the anogenital mucosa, carcinoma-like
condyloma, and condylomatoid precarcinosis; oroaer-
odigestivedAckerman tumor, VC of Ackerman, and oral
florid papillomatosis; the feetdepithelioma cuniculatum
and carcinoma cuniculatum; and other cutaneous
sitesdcutaneous VC, papillomatosis cutis carcinoid, and
papillomatosis cutis.1
This terminology is not uniformly applied, so a VC at any
site may be called any of the above names. No term except
VC, site specified, is probably of value.1
1.2. BuschkeeLoewenstein tumor
BLT is anogenital and aptly described as “grotesque,
cauliflower-like excrescences usually localized to the glans
penis.” It was originally described as a penile lesion by
Buschke in 1896 and by Loewenstein (BLT) in 1925.2,3 The
first description of anorectal GCA was by Dawson et al4 in
1965. It has been described as a low-grade and well-
differentiated carcinomatous process that displays
a marked tendency to compress and displace deeper tissues
by downward growth rather than infiltrating them or by
metastasizing.5 It is a VC of the anogenital mucosa. The BLT
is best defined as a type of VC, although some consider it to
be a separate entity6 or to be on a continuum between the
viral wart and VC rather than a VC per se.7VC is often found
within GCA, but it should be noted that VC can arise from
normal perianal skin without preceding condyloma. It is
evident that areas of invasion representing SCC can and do
arise within GCA. VC is unrelated to human papillomavirus
(HPV) and P53 inactivation, whereas BLT is related to both.8
Finally, in some publications, the terms VC, BLT, and GCA
are considered to be synonymous.9
We describe a case with multiple perianal lesions, since
the macroscopic features and the size of each lesion were
not sufficient to differentiate between simple condyloma,
anogenital warts, a more aggressive disease like GCA, and
the well-differentiated SCC. Consequently, optimal treat-
ment should follow the excision and histopathological
findings to decide which therapy is appropriate for the
diagnosed lesion.
A search was performed using the key words GCA and
BLT of the anus in all database search engines, in particularin the PubMed database. All articles describing cases of GCA
of anus were included. GCA of another region was excluded
from this study. Between 2000 and 2010, we found 36
publications in multiple languages that included, in addi-
tion to our case, another 63 cases of GCA of the anorectum
(Table 1). Three series of patients with BLT have been re-
ported; the first by Creasman et al in 1989; the second by
Chu et al in 1994;and the third by Trombetta et al in 2001.10
The table of results is designed in a similar way to that
published by Trombetta et al.10 The date assigned for each
case or series of cases is the publication year.
2. Case report
A 58-year-old man, of unknown sexual orientation, HIV,
hepatitis C, B negative, was admitted to the hospital for
multiple lesions located at the level of the perianal region
that had been present for years with progressive size
increase. At physical examination this vegetative lesion
presented as a cauliflower-like tumor measuring 14 cm in
length and 7 cm in diameter; it was hard, ulcerated, and
not painful. There were multiple small lesions around the
main one (Fig. 1). The rectal examination and the recto-
scopy showed the anal canal to be free of the disease. A
chest X-ray was normal. A computed tomography (CT) scan
of the pelvis/abdomen showed no infiltration of pelvic
muscles or para-aortic lymph nodes and no liver metastasis.
Preoperative biopsy and histological examination confirmed
the diagnosis of well-differentiated SCC, verrucous type.
The patient underwent laparoscopic closure and transec-
tion of the rectum using Endo-GIA at the peritoneal
reflection level with insertion of temporary end colostomy
using the sigmoid colon, followed 2 weeks later by local
full-thickness skin excision of six different specimens. The
defect was covered using skin flap technique (Fig. 2). The
patient developed wound infection near the OS coccyges
region, which was treated conservatively. The patient was
followed up for 1 year without any evidence of local
recurrences. He was lost to follow-up thereafter.
2.1. Methods of histopathologic examination
Representative pieces of tissue were cassetted and fixed
directly in 10% neutral formalin for 24 hours, followed by
dehydration in increasing concentrations of ethanol,
clearing with xylene and embedding in paraffin. Five-
micrometer sections were prepared from paraffin blocks
and stained with hematoxylin and eosin. The stained
sections were evaluated by the histopathologist who
participated in this project using light microscopy. Five-
micrometer sections were prepared from paraffin blocks for
in situ hybridization by DAKO HPV 6/11 and DAKO GenPoint
HPV DNA probe cocktail. Biotinylated HPV cocktail probes,
which identify the 13 most prevalent high-risk HPV gen-
otypesd16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and
68, were used following the standard technique.11
2.2. Results of histopathological examination
Microscopic examination of the condyloma acuminata
revealed acanthosis, papillomatosis, and parakeratosis
Table 1 Literature review of published cases with GCA 2000e2010.
First author/
publication year
_\/Age Sexual
orientation
HPV/HIV Therapy Follow-up Recurrence Additional
therapy
Pathology
Brahim B/200057 _/47 Homo NK/NK Local excision and
lymph-node
dissection inguinal
d d d GCA with
invasion only
in lymph node
Geusau A/200058 _/40 Hetero 6/neg Intralesional interferon
alpha therapy
28 mo
treatment þ
4 mo observation
No No BLT
Dolanc R/200256 \/56 No 6;11/neg Abdominoperineal excisionþ
radiotherapy 50 Gy
d d SCC in BLT
Frega A/200255 3 \/
21, 35, 52
Two patients
heterosexual,
one patient
pluripara
HPV 6, 11 in all/
all HIV neg
CO2 laser surgery excision
and vaporization
90e106 mo No No GCA
Ergun S/200354 _/60 Hetero 6/neg Local radical excision 13 mo No No GCA, no
significant
squamous
atypia
El Mejjad/200353 2 _ and 1 \ High-risk
sexual behavior
NK/NK Local radical excision d d d BLT
Heinzerling
LM/200351
\/82 NK 6b/NK Imiquimod þ laser d d d VC or BLT
Mestrovic T/200352 5 _; 1 \/
26e48
19
No anoreceptive
intercourse
1:un/neg
2: 16;18/neg
3: 6;11/neg
4: 6;11/neg
5: 6;11/neg
6: 6;11neg
All had radical excision,
in two abdominoperineal
excision had been
followed
5e10 y No No GCA in all
cases, in
two of them
an additional
SCC was found
Perisic Z/200350 \/28 Multipara 11/NK Surgical excision and CO2
laser
6 mo No No GCA
Parise P/200449 _/47 Hetero HPV 16/neg Radical local excision 12 mo No No BLT
Renzi A/200447 \/24 No sexual
promiscuity
NK/NK Surgical full-thickness
excision.
6 y No No GCA
Uribe N/200448 5 _
1 \
18e60
NK Four patients
HIV positive
Full thickness and
V-Y plastic
2 y No No GCA
Chao Michael
WT/200545
_/57 Hetero NK/neg Radiotherapy þ 5FU þ
mitomycin
1 y No No GCA with SCC
Qarro A/200546 3 cases/
26, 35, 38
NK NK/NK Full-thickness excision NK No No BLT
Mistrangelo
M/200544
3 _s NK NK/NK Extensive local surgical
treatment
d d d d
(continued on next page)
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Table 1 (continued)
First author/
publication year
_\/Age Sexual
orientation
HPV/HIV Therapy Follow-up Recurrence Additional
therapy
Pathology
Chaidemenos
G/200643
_/48 Hetero 5/neg Full-thickness resection
with mesh graft
1.5 y No No GCA
Renzi A/200642 \/24 No sexual
promiscuity
Un/un Surgical full-thickness
skin excision
2 y No No GCA
Hicheri J/200639 _/44 NK NK/NK Surgery d d d GCA, with
medium
dysplasia,
verrucous,
ortho- and
parakeratotic
epidermis,
acanthosis
Tytherleigh
MG/200640
2_/40,51 1:hetero HIV/neg Patient 1:
chemoradiation þ
surgery (APR)
Patient 2:
chemoradiation þ
surgery (APR)
Patient 1: 12 mo
Patient 2: 5 y
One patient
developed
recurrence
and died
thereafter
The other
recurrent free
No BLT
De Toma
G/200641
2_and 1 \/
46, 40, 65
1: hetero
1: trans
1: multipara
1: 6/neg
1: 6;11/pos
1: 6, 11/neg
Surgery þ interferon
Antiviral drug
Surgery
3 y
1 y
2 y
1drecurred
2drecurred
No recurrence
Another surgery
Surgery
1dVC, BLT
2d
3d
Rodriguez
C/200737
_/41 NK NK/pos Surgical/colostomy d d d GCA
Paraskevas
KI/200738
_/42 NK NK/NK Left colostomy þ
surgical resection
2 y No No GCA with VC
Klein N/200736 _/41 NK 33/neg Surgical excision 6 mo No No BLT
Chen-Guang
Z/200735
_/25 No sexual
contact
Positive/un Fulguration 12 mo Yes Surgery, local
interferon, BCG,
interleukin 2
GCA
Ganguly N/200834 _/38 Hetero 6, 11/neg Surgical þ
fulguration þ
5% imiquimod
cream
18 mo No Imiquimod cream GCA, no
dysplasia
Rahman
MM/200833
_/55 Male partner NK/NK Surgery d d No BLT
Gupta S/200832 2 _/16,26 NK NK/neg Intralesional
immunotherapy
with killed
Mycobacterium
w vaccine
4.5 mo d One complete
cleared and one
first after
additional
radiofrequency
BLT
46
F.
Sa
fi
e
t
a
l.
Gholam P/200931 _/50 Hetero 6, 11
10/26/20
10/neg
Loop colostomy;
surgical excision
5 y No No BLT, GCA
Handisurya
A/200930
_/45 NK 6, 11/pos Surgical intervention 6 mo Yes Palliative
surgery and
radiochemotherapy
Mid
differentiated
invasive SCC
Balik E/200928 3_ and 2\/
24e52
Two
patients
homo;
three
patients (un)
All HIV/
neg HPV
Surgical, full thickness Mean 22
moe5 y
No No BLT
Armstrong
N/200929
_/46 NK HPV 6, 11
HIV neg
Colostomy
Radiochemotherapy after
unsuccessful surgical
excision,
34 mo No No BLT
Ali Sbai M/200927 _/50 NK NK Surgical full-thickness
excision
NK NK No BLT
Talwar A/201026 _/42 Normal,
cocaine
and c2h5oh
abusus
NK Surgical excision after
colostomy
d BLT
Cusini M/201024 _/46 Homo 6, 11/pos Surgical excision þ
imiquimod cream 5%
3 y Yes Recurrent surgical
excision
BLT
Waqar H/201025 _/36 Hetero /neg Primary therapy recurrent
surgical excision
3 y Recurrence
of BLT þ VC,
well-
differentiated
SCC
Radiotherapy 54 Gy
and 5FY þ mitomycin C,
after this therapy
free at 6 mo
BLT with
conversion
to VC and
well-
differentiated
SCC
Perniola G/201023 \/69 NK HPV 6/pos
HIV neg
Surgical excision,
followed by CO2
laser vaporization; and
interferon therapy
3 y Yes CO2 laser vaporization
and systemic interferon
therapy, 3 y after
this therapy free
of recurrences
BLT
Safi F/2011 _/58 NK 6, 11, 16 and
18/neg
Surgical excision 1 y No No BLT,
simple wart
Total
36
Publication
\15
_48
n Z 63
*The location was in all patients perianal, in three women an addition to perianal vulva.
Fifteen females, age: 19e82 (median 52) years; 48 males, age: 16e60 (median 45) years.
APRZ Abdomino-perineal rectum resection; BLTZ BuschkeeLoewenstein tumor; GCAZ giant condyloma acuminatum; HPVZ human papillomavirus; negZ negative; NKZ not known;
pos Z positive; S Z Symptoms; SCC Z squamous-cell carcinoma; VC Z verrucous carcinoma.
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Figure 1 Pre-operative status of the disease.
48 F. Safi et al.(Fig. 3A), while VC showed papillary fronds of well-
differentiated squamous epithelium with extensive hyper-
keratosis and parakeratosis (Fig. 3B). The epithelium was
hyperplastic and had penetrated into the underlying tissues
in broad bulbous down-growths, in a pushing rather than
infiltrating pattern (Fig. 3C and D). The cells in the super-
ficial and intermediate layers showed extensive koilocy-
totic changes, morphologically identical to those of
condylomatous lesions (Fig. 3C and D). Tumor stroma was
infiltrated by abundant chronic inflammatory cells (Fig. 3C
and D). In situ hybridization with HPV 6/11 probe revealed
brown nuclear staining (thick arrow) (Fig. 3E); this nuclear
positivity was seen in both condylomata cells and VC cells.
In situ hybridization with high-risk cocktail probe revealed
brown nuclear staining (thick arrow) (Fig. 3F), the nuclear
positivity being seen in VC cells only.
3. Discussion
3.1. Etiology
In men who have sex with men (MSM), the anal region can
be used for obtaining sexual satisfaction. The prevalence ofFigure 2 Post-operative result after excision.homosexual intercourse has increased as has the practice of
receptive anal intercourse.12 Recent studies report an
alarming incidence of dysplasia in MSM, along with anal
condyloma that is caused by some types of the HPV. The
incidence of anal cancer among homosexual men exceeds
that of cervical cancer in women, and HIV-positive homo-
sexual men are at even higher risk than HIV-negative men.13
Goldie et al14 demonstrated that cytological screening
every 2 or 3 years for anal squamous intraepithelial lesions
in HIV-negative MSM, and every year in HIV-positive MSM,
would provide cost-effective life-expectancy benefits. In
this review, sexual orientation was mentioned in 33/63
patients with all kinds of sexual behaviors, and it appears
that significantly more patients in this new series are open
toward their sexual direction than before (Table 2).
Condyloma acuminatum is one of the most common
sexually transmitted infections. It is caused by one of
several HPVs depending on the skin site, of which more
than 70 subtypes have been described to date. HPV can be
transmitted via several pathways: sexual contact, auto-
inoculation, or contact with infected materials. Its incu-
bation period usually lasts 2e3 months, but can last for up
to 20 months. Risk factors for the development of anal/
perianal warts are immunosuppression, chronic irritation
such as perianal fistula and ulcerative colitis, and poor
personal hygiene.15
HPV (6, 11, 16, and 18) has been found in biopsy material
from BLT; this finding confirms the viral origin of condylo-
mata acuminata. HPV 6 and 11 are the two most commonly
found subtypes; they are usually nononcogenic or low risk.
The additional presence of HPV 16 and 18 within a condy-
loma already containing HPV 6 and 11 may be of signifi-
cance for the development of BLT.16 Many cases have been
reported as HPV negative.6 In the present review, hybrid-
izations for HPV were done in 28 out of 63 patients; HPV
was positive in 27 out of 28 patients (96%) and negative in
one. In the remaining 29 patients, hybridization was not
mentioned (Tables 1 and 2). HIV status was established in
42 patients; in 21 the test was not done. Eight patients out
of 42 tested were HIV positive, and the remaining 34 (81%)
were negative (Table 2). Palexas and Lecatsas17 mentioned
that malignant transformation of GCA has been docu-
mented in HIV-positive patients. In our review, nine out of
63 (14%) patients showed malignant transformation from
atypia to invasive SCC with lymph-node metastasis. Out of
the nine, seven were HIV negative and one positive, and the
HIV status of one was unknown. This finding does not
support the hypothesis that HIV increases the potential
malignant transformation in GCA patients.3.2. Incidence
Incidence rates of BLT reported in the literature vary,
possibly because of difficulties in histomorphologic differ-
entiation between simple warts, VC, and SCC, and because
of the lack of epidemiological studies.
Penile VC is more common than anogenital or mouth
VC.18 The annual incidence of condyloma acuminatum in
the United States is 1%; an incidence similar to that is re-
ported in the United Kingdom, Panama, Italy, and other
developed countries. There are no published epidemiologic
Figure 3 Histology and immuno-staining findings.
Management of perianal giant condyloma acuminatum 49data in developing countries. In the last millennium, 1.2
cases per year were reported in the literature; in our
review of the last 10 years, this increased to 6.3 cases per
year (Table 2). It remains an uncommon problem in chil-
dren. Whenever it is found in children, the possibility of
sexual abuse must be investigated.19
Fifteen of the cases included in this review were female
and 48 male (ratio 3.2:1). The mean age at presentation
was 42 years (range 16e82 years). These data are similar to
those of Trombetta et al.10 The incidence in males is
significantly higher than in females, which may be due to
homosexuality.3.3. Histological features and malignant
transformation
GCA/BLT infiltrate or pushing of the underlying tissues is
locally destructive without metastatic potential. These
histological features are similar to simple condyloma or
pseudoepitheliomatous hyperplasia (see histologicalfeatures of our case). In some areas, it develops low- or
high-grade carcinoma, and some cases display invasive
growth with metastasis. The mechanisms of transformation
are not clear; it could be provoked by radiotherapy, similar
to changes observed inwarts after radiation.20 In our case,
we found three simple condyloma and three others with
SCC in the same perianal area. This supports the
hypothesis that condyloma acuminatum, GCA, and VC
may represent a "contiguous but not obligatorily
a precancerous spectrum" and that age, size, and pres-
ence or absence of recurrences do not correlate with
histological diagnosis.7,10
The malignant transformation rate or the incidence of
SCC in GCA reported in the literature was between 30%
and 56%, with a significant increase in transformation rate
from 12.5% in 1960 to 75% in 1980; the average time of
transformation was about 5 years.15 Trombetta et al10
reports no invasion in 42% of GCA and carcinoma in situ
in 8% of GCA, and in 50% of cases the histology demon-
strated invasion of cancer classified as VC, SCC, or basa-
loid carcinoma. Reicenbauch et al21 mentioned a lower
Table 2 Comparison of reviews.
Factors Safi et al Trombetta et al
Period of observation 2000e2010 (10 y) 1958e2000 (42 y)
Number of cases 63 52
Cases per year 6.3 1.2
Gender M/F 48/15; 3:1 38/14; 2.7:1
Age (y) 16e82 (mean 42) 24e77 (mean 42)
Sexual orientation
Unknown 29 41
Heterosexual 12 06
Homosexual 04 04
Bisexual 00 01
High risk 04 00
No sexual contact 03 00
Trans-sexual 01 00
Multipara 04 00
No anoreceptive intercourse 06 00
Initial therapy
Patient treated 63 52
Unknown recurrence 16 07
Recurrence 08/47 (17%) 29/45 (64%)
Recurrence free 39/47 (83%) 16/45 (26%)
Surgical therapy 57/63 (90%) 45/52 (87%)
Other nonsurgical 06/63 (10%) 7/52 (13%)
HPV
Unknown 35 d
Positive 27/28 (96%)
Negative 01/28 (4%)
HIV
Unknown 21 d
Positive 08/42 (19%)
Negative 34/42 (81%)
All the cases published by Creasman et al (1989) and by Chu et al are included by Tombetta et al, except two publications: Prasad, and
Baird et al. The current study is compared with that of Trombetta et al.
HPV Z human papillomavirus.
50 F. Safi et al.transformation rate of 8.5% in men and 12.5% in women.
Malignant transformation in simple warts was found but
with a significantly lower incidence rate of 1.8%,.4 In the
present review, the transformation rate is 9/63 (14%) in
both sexes.
3.4. Symptoms and diagnosis
Clinically, condyloma acuminatum manifests itself by
multiple verrucous lesions. The presence of local infiltra-
tion by a cauliflower-like exophytic lesion is rarely seen,
but when this does occur it is known as GCA or BLT.
The symptoms at first presentation are mainly a mass or
multiple masses as in our patient. Sizes range between
1.2  0.6  0.4 and 14  7  4 cm3. Other symptoms
including pain, fistula, abscess, persistent drainage,
bleeding, pruritus, difficulty in walking, and defecation
may present alone or combined. Clinical examination shows
masses that are mobile toward the deep fascia and tissues.
There is no difference in clinical presentation between our
series and that of Trombetta et al.10From clinical examination, there is no way to differen-
tiate between the multiple lesionsdwhether they are anal
warts, condyloma acuminatum, GCA, or VC. A biopsy of one
lesion followed by histological examination will not provide
definitive histological features. Only complete excision of
the lesions and histological examination can provide a final
pathological diagnosis.
3.5. Therapy
Cryosurgery and topical application of 25e30% podophyllin
or trichloroacetic acid are indicated for small lesions of
anal condyloma acuminatum, the failure rate being 25%.
Interferon therapy or chemotherapy, either intralesional or
systemic intravenous, has been used to shrink the tumor
prior to surgery, thus facilitating surgical excision. The use
of radiotherapy is controversial as VC may transform into
poorly differentiated carcinoma with subsequent metas-
tases. CO2 laser therapy can be applied with success.
10
The BLT is locally aggressive and destructive, pene-
trating surrounding tissues irrespective of whether there is
Management of perianal giant condyloma acuminatum 51malignant transformation or not. Therefore, the basic
approach to this tumor is surgical, with microscopically
controlled dissection to allow total tumor removal with
maximum preservation of normal tissue structure and
function, and to allow complete histological examination of
the tumor for areas of frankly invasive SCC.
There are two main problems concerning surgical
treatment. Firstly, there is a high recurrence rate of
60e66%15 after radical local excision. Abdominoperineal
operation is recommended only if there is pelvic involve-
ment. The second problem is the localization of the tumor
and postoperative wound healing in presence of feces.
Temporary loop colostomy is recommended by several
authors to avoid contamination.22 We believe that laparo-
scopic blind closure of the rectum with terminal left
colostomy can achieve a clean area more effectively.
Surgical excision is still the first line of treatment for
anal BLT, with a higher success rate (63e91%) and lower
relapse rate. Chu et al15 concluded that an effective
treatment is wide surgical excision of the tumor, with or
without adjuvant chemotherapy. In this review and the
previous one, 90% and 87%, respectively, of the cases were
treated surgically. Many surgical terminologies have been
used. Trombetta et al refer to biopsy, simple excision, wide
local excision, radical operation, and abdominoperineal
excision; in this review, we have wide local excision, full-
thickness excision, abdominoperineal excision, and laser
excision. None of these treatment modalities has a precise
definition. We believe that the R0 surgical resection proven
by exact histological examination to all margins is the term
of choice. The efficacy of other nonsurgical treatment
modalities should be proved in the future.
In summary, the reported incidence of perianal GCA has
increased dramatically in the last 10 years. It affects men
more than women. The mean age is still 42 years. The
histological features are defined with or without the pres-
ence of invasive cancer. Nearly all surgical specimens show
HPV. The relation between HIV and the presence of invasive
cancer is not clear. The main therapy is still surgical
with histological proof of R0 resection. The effect of
additional or other nonsurgical therapy modalities is not yet
established. Multicenter studies are urgently needed for
more understanding of the disease, its prognosis, and its
treatment.
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